{
  "Variants Include": [
    {
      "Gene": "PARK7",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "A",
            "alt": "I",
            "position": "26"
          },
          "Protein Change": {
            "ref": "M",
            "alt": "I",
            "position": "26"
          },
          "Description in input context": "M26I"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "T",
            "alt": "P",
            "position": "166"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "P",
            "position": "166"
          },
          "Description in input context": "L166P"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0001985"
  },
  "Experiment Method": [
    {
      "Assay Method": "Yeast two-hybrid screening",
      "Material used": {
        "Material Source": "Human fetal brain library",
        "Material Name": "Human fetal brain cDNA library",
        "Description": "Yeast two-hybrid screening was performed using a human fetal brain cDNA library to identify TTRAP as a novel DJ-1 interactor."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Dominant-negative",
          "Result Description": "Mutant DJ-1 (M26I and L166P) exhibited enhanced binding to TTRAP compared to wild-type DJ-1, disrupting TTRAP-mediated cytoprotection."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple independent screenings were conducted to validate TTRAP-DJ-1 interactions."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each interaction was confirmed using independent yeast transformations."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type DJ-1 was used as a positive control for TTRAP interaction."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or unrelated bait constructs served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Binding affinity within physiological range (custom threshold based on literature).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Binding affinity >2-fold higher than wild-type (custom threshold based on literature).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Apoptosis protection assay",
      "Material used": {
        "Material Source": "Neuroblastoma cells",
        "Material Name": "SH-SY5Y cells",
        "Description": "TTRAP-mediated cytoprotection against apoptosis was assessed in SH-SY5Y cells expressing wild-type or mutant DJ-1."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss of cytoprotective function",
          "Result Description": "Mutant DJ-1 (M26I and L166P) failed to protect cells from apoptosis, leading to JNK/p38-MAPK activation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were repeated in triplicate across independent cell cultures."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each condition was tested in quadruplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type DJ-1-expressing cells served as positive controls for cytoprotection."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells were used as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test (p < 0.05)."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Apoptosis <10% of baseline (based on literature).",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Apoptosis >30% of baseline (based on literature).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}